BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $16.00K; Additional Paid in Capital, Common StockUSD $231.43M; Treasury Stock, Common, ValueUSD $116.00K; Retained Earnings (Accumulated Deficit)USD $-242.93M.
- 2026-03-31: Common Stock, Value, IssuedUSD $16.00K; Additional Paid in Capital, Common StockUSD $228.16M; Treasury Stock, Common, ValueUSD $116.00K; Retained Earnings (Accumulated Deficit)USD $-239.07M.
- 2025-12-31: Common Stock, Value, IssuedUSD $16.00K; Additional Paid in Capital, Common StockUSD $227.06M; Treasury Stock, Common, ValueUSD $116.00K; Retained Earnings (Accumulated Deficit)USD $-236.94M.
- 2025-09-30: Common Stock, Value, IssuedUSD $16.00K; Additional Paid in Capital, Common StockUSD $226.92M; Treasury Stock, Common, ValueUSD $116.00K; Retained Earnings (Accumulated Deficit)USD $-234.51M.
BRAINSTORM CELL THERAPEUTICS INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Common, Value USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16.00K | $231.43M | $116.00K | $-242.93M | $-11.60M | (m) |
| 2026-03-31 | $16.00K | $228.16M | $116.00K | $-239.07M | $-11.01M | (m) |
| 2025-12-31 | $16.00K | $227.06M | $116.00K | $-236.94M | $-9.98M | (m) |
| 2025-09-30 | $16.00K | $226.92M | $116.00K | $-234.51M | $-7.69M | (m) |
| 2025-06-30 | $16.00K | $226.45M | $116.00K | (m) | $-6.06M | (m) |
| 2025-03-31 | $15.00K | $222.14M | $116.00K | $-229.50M | $-7.46M | (m) |
| 2024-12-31 | $14.00K | $218.97M | $116.00K | $-226.64M | $-7.76M | (m) |
| 2024-09-30 | $14.00K | $217.71M | $116.00K | $-223.66M | $-6.06M | (m) |
| 2024-06-30 | $14.00K | $217.53M | $116.00K | $-220.96M | $-3.53M | (m) |
| 2024-03-31 | $13.00K | $212.97M | $116.00K | $-218.41M | $-5.55M | (m) |
| 2023-12-31 | $13.00K | $210.26M | $116.00K | $-215.01M | $-4.86M | (m) |
| 2023-09-30 | $12.00K | $206.96M | $116.00K | $-209.44M | $-2.58M | (m) |
| 2023-06-30 | $12.00K | $204.43M | $116.00K | $-208.21M | $-3.88M | (m) |
| 2023-03-31 | $12.00K | $198.14M | $116.00K | $-202.88M | $-4.84M | (m) |
| 2022-12-31 | $12.00K | $194.91M | $116.00K | $-197.82M | $-3.02M | (m) |
| 2022-09-30 | $12.00K | $194.29M | $116.00K | $-192.80M | $1.39M | (m) |
| 2022-06-30 | $12.00K | $193.90M | $116.00K | $-185.94M | $7.85M | (m) |
| 2022-03-31 | $12.00K | $193.50M | $116.00K | $-178.90M | $14.49M | (m) |
| 2021-12-31 | $12.00K | $192.99M | $116.00K | $-173.54M | $19.34M | (m) |
| 2021-09-30 | $12.00K | $192.38M | $116.00K | $-167.35M | $24.93M | (m) |
| 2021-06-30 | $12.00K | $192.29M | $116.00K | $-162.02M | $30.17M | (m) |
| 2021-03-31 | $12.00K | $192.05M | $116.00K | $-155.75M | $36.20M | (m) |
| 2020-12-31 | $12.00K | $184.66M | $116.00K | $-149.09M | $35.46M | (m) |
| 2020-09-30 | $12.00K | $163.24M | (m) | $-137.27M | $25.98M | (m) |
| 2020-06-30 | $12.00K | $142.59M | (m) | $-132.78M | $9.82M | (m) |
| 2020-03-31 | $12.00K | $134.39M | (m) | $-125.39M | $9.01M | (m) |
| 2019-12-31 | $11.00K | $105.04M | $0.00 | $-117.28M | $-12.22M | (m) |
| 2019-09-30 | $11.00K | $102.80M | (m) | $-109.58M | $-6.78M | (m) |
| 2019-06-30 | $11.00K | $99.42M | (m) | $-103.95M | $-4.52M | (m) |
| 2019-03-31 | $11.00K | $98.33M | (m) | $-99.05M | $326.00K | (m) |
| 2018-12-31 | $11.00K | $94.62M | (m) | $-94.02M | $5.02M | (m) |
| 2018-09-30 | $11.00K | $94.20M | (m) | $-88.64M | $9.98M | (m) |
| 2018-06-30 | $11.00K | $93.94M | (m) | $-85.46M | $12.87M | (m) |
| 2018-03-31 | $11.00K | $86.20M | (m) | $-82.37M | $3.83M | (m) |
| 2017-12-31 | $11.00K | $85.94M | (m) | $-80.08M | $5.88M | (m) |
| 2017-09-30 | $11.00K | $85.53M | (m) | $-80.35M | $5.20M | (m) |
| 2017-06-30 | $11.00K | $85.23M | (m) | $-77.95M | $7.29M | (m) |
| 2017-03-31 | $11.00K | $85.14M | (m) | $-76.91M | $8.24M | (m) |
| 2016-12-31 | $11.00K | $85.01M | (m) | $-75.12M | $9.90M | (m) |
| 2016-09-30 | $11.00K | $85.02M | (m) | $-74.50M | $10.53M | (m) |
| 2016-06-30 | $11.00K | $84.75M | (m) | $-72.89M | $11.87M | (m) |
| 2016-03-31 | $11.00K | $84.49M | (m) | $-71.93M | $12.57M | (m) |
| 2015-12-31 | $11.00K | $84.26M | (m) | $-70.14M | $14.13M | (m) |
| 2015-09-30 | $13.00K | $84.27M | (m) | $-68.76M | $15.52M | (m) |
| 2015-06-30 | $13.00K | $83.98M | (m) | $-66.15M | $17.84M | (m) |
| 2015-03-31 | $13.00K | $83.54M | (m) | $-63.89M | $19.66M | (m) |
| 2014-12-31 | $11.00K | $68.32M | (m) | $-61.65M | $6.67M | (m) |
| 2014-09-30 | $10.00K | $67.81M | (m) | $-58.92M | $8.90M | (m) |
| 2014-06-30 | $10.00K | $67.09M | (m) | (m) | $10.60M | (m) |
| 2014-03-31 | $8.00K | $55.37M | (m) | (m) | $860.00K | (m) |
| 2013-12-31 | $8.00K | $55.14M | (m) | $-52.41M | $2.74M | (m) |
| 2013-09-30 | $8.00K | $55.72M | (m) | (m) | $4.54M | (m) |
| 2013-06-30 | $7.00K | $52.46M | (m) | (m) | $2.35M | (m) |
| 2013-03-31 | $7.00K | $52.06M | (m) | (m) | $3.48M | (m) |
| 2012-12-31 | $7.00K | $51.48M | (m) | (m) | $3.98M | (m) |
| 2012-09-30 | $7.00K | $51.38M | (m) | (m) | $4.46M | (m) |
| 2012-06-30 | $6.00K | $46.03M | (m) | (m) | $253.00K | (m) |
| 2012-03-31 | $6.00K | $45.76M | (m) | (m) | $817.00K | (m) |
| 2011-12-31 | $6.00K | $45.56M | (m) | (m) | $1.49M | (m) |
| 2011-09-30 | $6.00K | $44.99M | (m) | (m) | $2.34M | (m) |
| 2011-06-30 | $6.00K | $44.20M | (m) | (m) | $2.25M | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | $2.67M | (m) |
| 2010-12-31 | $5.00K | $39.70M | (m) | (m) | $-459.00K | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | $-1.74M | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | $-2.08M | (m) |
| 2007-12-31 | (m) | (m) | (m) | (m) | $-2.43M | (m) |
| 2006-12-31 | (m) | (m) | (m) | (m) | $-1.82M | (m) |
| 2006-03-31 | (m) | (m) | (m) | (m) | $-7.91M | (m) |
| 2005-03-31 | (m) | (m) | (m) | (m) | $704.00K | 12 month · $7.00K |
| 2004-03-31 | (m) | (m) | (m) | (m) | $-31.00K | 12 month · $15.00K |
| 2003-03-31 | (m) | (m) | (m) | (m) | $21.00K | 12 month · $15.00K |
| 2002-03-31 | (m) | (m) | (m) | (m) | $53.00K | 12 month · $11.00K |
| 2001-03-31 | (m) | (m) | (m) | (m) | $68.00K | 6 month · $8.00K |
| 2000-09-24 | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2000-09-22 | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2000-09-21 | (m) | (m) | (m) | (m) | $0.00 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |